Is STIM or MDAI more profitable?

Neuronetics has a net margin of -19.62% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Neuronetics' return on equity. Company Net Margins Return on Equity Return on Assets Neuronetics -19.62% -125.11% -22.15% Spectral AI -69.27% N/A -78.56%

Is FOCL or MDAI more profitable?

FocalTherics has a net margin of -56.26% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat FocalTherics' return on equity. Company Net Margins Return on Equity Return on Assets FocalTherics -56.26% -248.00% -44.69% Spectral AI -69.27% N/A -78.56%

Do analysts rate MDAI or ZJYL?

Spectral AI currently has a consensus price target of $4.00, indicating a potential upside of 140.96%. Given Spectral AI's stronger consensus rating and higher possible upside, research analysts plainly believe Spectral AI is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Spectral AI 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, MDAI or ZJYL?

Jin Medical International has higher revenue and earnings than Spectral AI. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Spectral AI $15.39M 3.47 -$7.57M -$0.35 N/A Jin Medical International $19.73M 7.71 $1.19M N/A N/A

Is MDAI or ZJYL more profitable?

Jin Medical International has a net margin of 0.00% compared to Spectral AI's net margin of -69.27%. Company Net Margins Return on Equity Return on Assets Spectral AI -69.27% N/A -78.56% Jin Medical International N/A N/A N/A

Which has stronger valuation and earnings, OWLT or MDAI?

Spectral AI has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Owlet $105.70M 1.39 -$39.68M -$0.75 N/A Spectral AI $15.39M 3.47 -$7.57M -$0.35 N/A

Is OWLT or MDAI more profitable?

Owlet has a net margin of -8.61% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Owlet -8.61% -601.24% -15.96% Spectral AI -69.27% N/A -78.56%

Does the media prefer OWLT or MDAI?

In the previous week, Spectral AI had 1 more articles in the media than Owlet. MarketBeat recorded 2 mentions for Spectral AI and 1 mentions for Owlet. Owlet's average media sentiment score of 1.97 beat Spectral AI's score of 0.00 indicating that Owlet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owlet 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Spectral AI 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer INGN or MDAI?

Spectral AI has a consensus target price of $4.00, indicating a potential upside of 140.96%. Given Spectral AI's stronger consensus rating and higher probable upside, analysts clearly believe Spectral AI is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Spectral AI 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67

Which has better earnings & valuation, INGN or MDAI?

Spectral AI has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inogen $348.67M 0.45 -$22.75M -$0.90 N/A Spectral AI $15.39M 3.47 -$7.57M -$0.35 N/A

Is INGN or MDAI more profitable?

Inogen has a net margin of -6.94% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Inogen's return on equity. Company Net Margins Return on Equity Return on Assets Inogen -6.94% -13.17% -8.36% Spectral AI -69.27% N/A -78.56%

Does the media prefer INGN or MDAI?

In the previous week, Inogen had 4 more articles in the media than Spectral AI. MarketBeat recorded 6 mentions for Inogen and 2 mentions for Spectral AI. Inogen's average media sentiment score of 0.33 beat Spectral AI's score of 0.00 indicating that Inogen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inogen 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Spectral AI 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Spectral AI (MDAI) Competitors

$1.66 0.00 (0.00%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$1.63 -0.03 (-2.05%)

As of 10/2/2026 07:56 PM Eastern

Compare

MDAI vs. STIM, FOCL, ZJYL, OWLT, and INGN

Should you buy Spectral AI stock or one of its competitors? Spectral AI's main competitors and comparable companies include Neuronetics (STIM), FocalTherics (FOCL), Jin Medical International (ZJYL), Owlet (OWLT), and Inogen (INGN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Spectral AI compare to Neuronetics?

Neuronetics (NASDAQ:STIM) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

In the previous week, Spectral AI had 2 more articles in the media than Neuronetics. MarketBeat recorded 2 mentions for Spectral AI and 0 mentions for Neuronetics. Neuronetics' average media sentiment score of 0.00 equaled Spectral AI'saverage media sentiment score.

Company	Overall Sentiment
Neuronetics	Neutral
Spectral AI	Neutral

Neuronetics has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market. Comparatively, Spectral AI has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market.

Neuronetics has a net margin of -19.62% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-19.62%	-125.11%	-22.15%
Spectral AI	-69.27%	N/A	-78.56%

53.6% of Neuronetics shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 8.4% of Neuronetics shares are owned by company insiders. Comparatively, 13.7% of Spectral AI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Neuronetics presently has a consensus price target of $4.67, indicating a potential upside of 116.05%. Spectral AI has a consensus price target of $4.00, indicating a potential upside of 140.96%. Given Spectral AI's stronger consensus rating and higher probable upside, analysts plainly believe Spectral AI is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Spectral AI has lower revenue, but higher earnings than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$155.10M	1.06	-$39M	-$0.44	N/A
Spectral AI	$15.39M	3.47	-$7.57M	-$0.35	N/A

Summary

Spectral AI beats Neuronetics on 12 of the 16 factors compared between the two stocks.

How does Spectral AI compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

Spectral AI has lower revenue, but higher earnings than FocalTherics. Spectral AI is trading at a lower price-to-earnings ratio than FocalTherics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FocalTherics	$70.53M	2.23	-$29.25M	-$1.03	N/A
Spectral AI	$15.39M	3.47	-$7.57M	-$0.35	N/A

FocalTherics has a net margin of -56.26% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FocalTherics	-56.26%	-248.00%	-44.69%
Spectral AI	-69.27%	N/A	-78.56%

62.7% of FocalTherics shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 10.1% of FocalTherics shares are owned by insiders. Comparatively, 13.7% of Spectral AI shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

FocalTherics currently has a consensus target price of $7.75, indicating a potential upside of 84.52%. Spectral AI has a consensus target price of $4.00, indicating a potential upside of 140.96%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts clearly believe Spectral AI is more favorable than FocalTherics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FocalTherics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

FocalTherics has a beta of -0.06, suggesting that its stock price is 106% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market.

In the previous week, Spectral AI had 2 more articles in the media than FocalTherics. MarketBeat recorded 2 mentions for Spectral AI and 0 mentions for FocalTherics. FocalTherics' average media sentiment score of 0.00 equaled Spectral AI'saverage media sentiment score.

Company	Overall Sentiment
FocalTherics	Neutral
Spectral AI	Neutral

Summary

Spectral AI beats FocalTherics on 10 of the 14 factors compared between the two stocks.

How does Spectral AI compare to Jin Medical International?

Spectral AI (NASDAQ:MDAI) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

Jin Medical International has higher revenue and earnings than Spectral AI.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$15.39M	3.47	-$7.57M	-$0.35	N/A
Jin Medical International	$19.73M	7.71	$1.19M	N/A	N/A

Jin Medical International has a net margin of 0.00% compared to Spectral AI's net margin of -69.27%.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-69.27%	N/A	-78.56%
Jin Medical International	N/A	N/A	N/A

67.1% of Spectral AI shares are held by institutional investors. 13.7% of Spectral AI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Spectral AI currently has a consensus price target of $4.00, indicating a potential upside of 140.96%. Given Spectral AI's stronger consensus rating and higher possible upside, research analysts plainly believe Spectral AI is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Spectral AI has a beta of 1.21, indicating that its stock price is 21% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.41, indicating that its stock price is 641% more volatile than the broader market.

In the previous week, Spectral AI had 2 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for Spectral AI and 0 mentions for Jin Medical International. Spectral AI's average media sentiment score of 0.00 equaled Jin Medical International'saverage media sentiment score.

Company	Overall Sentiment
Spectral AI	Neutral
Jin Medical International	Neutral

Summary

Spectral AI beats Jin Medical International on 7 of the 13 factors compared between the two stocks.

How does Spectral AI compare to Owlet?

Owlet (NYSE:OWLT) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

Owlet has a beta of 1.91, indicating that its share price is 91% more volatile than the broader market. Comparatively, Spectral AI has a beta of 1.21, indicating that its share price is 21% more volatile than the broader market.

Spectral AI has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Owlet	$105.70M	1.39	-$39.68M	-$0.75	N/A
Spectral AI	$15.39M	3.47	-$7.57M	-$0.35	N/A

72.6% of Owlet shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 36.2% of Owlet shares are owned by insiders. Comparatively, 13.7% of Spectral AI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Spectral AI had 1 more articles in the media than Owlet. MarketBeat recorded 2 mentions for Spectral AI and 1 mentions for Owlet. Owlet's average media sentiment score of 1.97 beat Spectral AI's score of 0.00 indicating that Owlet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Owlet	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Spectral AI	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Owlet presently has a consensus price target of $15.00, indicating a potential upside of 197.62%. Spectral AI has a consensus price target of $4.00, indicating a potential upside of 140.96%. Given Owlet's higher possible upside, equities research analysts plainly believe Owlet is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Owlet has a net margin of -8.61% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Owlet	-8.61%	-601.24%	-15.96%
Spectral AI	-69.27%	N/A	-78.56%

Summary

Owlet beats Spectral AI on 9 of the 17 factors compared between the two stocks.

How does Spectral AI compare to Inogen?

Inogen (NASDAQ:INGN) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

Inogen has a net margin of -6.94% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-6.94%	-13.17%	-8.36%
Spectral AI	-69.27%	N/A	-78.56%

Spectral AI has a consensus target price of $4.00, indicating a potential upside of 140.96%. Given Spectral AI's stronger consensus rating and higher probable upside, analysts clearly believe Spectral AI is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Spectral AI has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$348.67M	0.45	-$22.75M	-$0.90	N/A
Spectral AI	$15.39M	3.47	-$7.57M	-$0.35	N/A

Inogen has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market. Comparatively, Spectral AI has a beta of 1.21, indicating that its share price is 21% more volatile than the broader market.

In the previous week, Inogen had 4 more articles in the media than Spectral AI. MarketBeat recorded 6 mentions for Inogen and 2 mentions for Spectral AI. Inogen's average media sentiment score of 0.33 beat Spectral AI's score of 0.00 indicating that Inogen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inogen	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Spectral AI	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

89.9% of Inogen shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 2.5% of Inogen shares are owned by company insiders. Comparatively, 13.7% of Spectral AI shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Spectral AI beats Inogen on 9 of the 16 factors compared between the two stocks.

Get Spectral AI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MDAI vs. The Competition

Export

Metric	Spectral AI	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$53.43M	$5.45B	$7.14B	$13.18B
Dividend Yield	N/A	1.80%	2.53%	16.78%
P/E Ratio	-4.74	24.90	275.97	26.04
Price / Sales	3.47	84.87	669.23	109.59
Price / Cash	N/A	32.43	77.60	51.75
Price / Book	-8.74	5.73	10.93	6.31
Net Income	-$7.57M	$152.68M	$3.51B	$362.16M
7 Day Performance	4.40%	-1.71%	-2.00%	-1.66%
1 Month Performance	6.41%	-4.81%	-6.15%	-4.50%
1 Year Performance	-25.56%	1.08%	7.44%	2.06%

Spectral AI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MDAI Spectral AI	1.8238 of 5 stars	$1.66 flat	$4.00 +141.0%	-29.4%	$53.43M	$15.39M	N/A	65	News Coverage
STIM Neuronetics	3.759 of 5 stars	$2.36 -7.8%	$4.67 +97.7%	-19.1%	$194.68M	$155.10M	N/A	658	Gap Down
FOCL FocalTherics	4.6052 of 5 stars	$4.54 +0.2%	$7.75 +70.7%	N/A	$170M	$70.53M	N/A	230	News Coverage
ZJYL Jin Medical International	N/A	$1.88 -3.6%	N/A	-83.3%	$152.94M	$19.73M	N/A	273
OWLT Owlet	3.2148 of 5 stars	$5.25 +2.6%	$15.00 +186.0%	-40.4%	$149.32M	$105.70M	N/A	114	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MDAI) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Spectral AI (MDAI) Competitors

MDAI vs. STIM, FOCL, ZJYL, OWLT, and INGN

How does Spectral AI compare to Neuronetics?

Summary

How does Spectral AI compare to FocalTherics?

Summary

How does Spectral AI compare to Jin Medical International?

Summary

How does Spectral AI compare to Owlet?

Summary

How does Spectral AI compare to Inogen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDAI vs. The Competition

Spectral AI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Spectral AI (MDAI) Competitors

MDAI vs. STIM, FOCL, ZJYL, OWLT, and INGN

How does Spectral AI compare to Neuronetics?

Does the media favor STIM or MDAI?

Which has more risk and volatility, STIM or MDAI?

Is STIM or MDAI more profitable?

Do insiders & institutionals believe in STIM or MDAI?

Do analysts recommend STIM or MDAI?

Which has higher valuation & earnings, STIM or MDAI?

Summary

How does Spectral AI compare to FocalTherics?

Which has preferable valuation and earnings, FOCL or MDAI?

Is FOCL or MDAI more profitable?

Do insiders and institutionals believe in FOCL or MDAI?

Do analysts prefer FOCL or MDAI?

Which has more volatility and risk, FOCL or MDAI?

Does the media favor FOCL or MDAI?

Summary

How does Spectral AI compare to Jin Medical International?

Which has better earnings and valuation, MDAI or ZJYL?

Is MDAI or ZJYL more profitable?

Do institutionals & insiders have more ownership in MDAI or ZJYL?

Do analysts rate MDAI or ZJYL?

Which has more volatility and risk, MDAI or ZJYL?

Does the media refer more to MDAI or ZJYL?

Summary

How does Spectral AI compare to Owlet?

Which has more volatility and risk, OWLT or MDAI?

Which has stronger valuation and earnings, OWLT or MDAI?

Do insiders and institutionals have more ownership in OWLT or MDAI?

Does the media prefer OWLT or MDAI?

Do analysts prefer OWLT or MDAI?

Is OWLT or MDAI more profitable?

Summary

How does Spectral AI compare to Inogen?

Is INGN or MDAI more profitable?

Do analysts prefer INGN or MDAI?

Which has better earnings & valuation, INGN or MDAI?

Which has more volatility & risk, INGN or MDAI?

Does the media prefer INGN or MDAI?

Do insiders & institutionals have more ownership in INGN or MDAI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MDAI vs. The Competition

Spectral AI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools